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A B S T R A C T
For drug delivery, characterization of liposomes regarding size, particle number concentrations,
occurrence of low-sized liposome artefacts and drug encapsulation are of importance to understand their
pharmacodynamic properties. In our study, we aimed to demonstrate the applicability of nano
Electrospray Gas-Phase Electrophoretic Mobility Molecular Analyser (nES GEMMA) as a suitable
technique for analyzing these parameters. We measured number-based particle concentrations,
identiﬁed differences in size between nominally identical liposomal samples, and detected the presence
of low-diameter material which yielded bimodal particle size distributions. Subsequently, we compared
these ﬁndings to dynamic light scattering (DLS) data and results from light scattering experiments
coupled to Asymmetric Flow-Field Flow Fractionation (AF4), the latter improving the detectability of
smaller particles in polydisperse samples due to a size separation step prior detection. However, the
bimodal size distribution could not be detected due to method inherent limitations. In contrast, cryo
transmission electron microscopy corroborated nES GEMMA results. Hence, gas-phase electrophoresis
proved to be a versatile tool for liposome characterization as it could analyze both vesicle size and size
distribution. Finally, a correlation of nES GEMMA results with cell viability experiments was carried out to
demonstrate the importance of liposome batch-to-batch control as low-sized sample components
possibly impact cell viability.
ã 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Liposomes are artiﬁcial vesicles formed by one or more
concentric phospholipid bilayers that are separated by aqueous
water compartments (Munin and Edwards-Levy, 2011). Within the
aqueous compartments and the lipid membrane they have theAbbreviations: AF4, Asymmetric Flow-Field Flow Fractionation; CPC, Condensation
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in the 60s’ (Bangham et al., 1962) and have gained widespread use
during the last decades as versatile drug carriers, cellular
transfection agents and carriers of diverse contrast agents among
other things (Allen and Cullis, 2013; Burdinski et al., 2010; Particle Counter; DLS, Dynamic Light Scattering; EM, Electrophoretic Mobility;
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may be unilamellar or multilamellar with spatial dimensions
(sizes) ranging from tens of nanometers to tens of micrometers.
For drug delivery purposes, liposome size, size distribution and
vesicle numbers per sample volume are of great importance. These
factors affect passive targeting and accumulation around tumor
areas, the so-called Enhanced Permeability and Retention (EPR)
effect, sedimentation and biodistribution, but also the amount of
drug that can be encapsulated within the liposome (Drummond
et al., 1999). For optimal drug delivery, liposomes should have a
size between 70 up to 300 nm and are usually protected by a steric
shield, like PEGylation, to avoid vesicle detection by the
reticuloendothelial system (Hupfeld et al., 2006; Nag and Awasthi,
2013). To date, several liposomal drugs have been approved by the
US Food and Drug Administration (FDA) like Marqibo (liposomal
vinCRIStine), Myocet and DOXIL/Caelyx (liposomal doxorubicin)
(Allen and Cullis, 2013). The liposomes used in this study are of a
similar lipid composition to that of DOXIL/Caelyx, differing only in
lipid molar ratios.
Characterization of liposomes has always been challenging and
still, to date no technique offers a full range analysis without any
drawbacks or the need of complementary data to make a full
characterization of the lipid vesicles. Among the common
techniques used for characterization of liposomes are (cryo)
Transmission Electron Microscopy (TEM), negative stain and
freeze-fracture Electron Microscopy, Atomic Force Microscopy
(AFM), Size Exclusion Chromatography (SEC) and Dynamic/Static
Light Scattering (DLS/SLS).
For instance, electron microscopy techniques are suitable for
surface and morphological studies of analytes but have several
drawbacks. Apart from cost-related issues, sample preparation and
sample analysis being carried out in vacuo might affect vesicle
shape (Almgren et al., 2000; Bibi et al., 2011). AFM is also suitable
for characterization of liposome shape, morphology and surface
properties. In contrast to Electron Microscopy techniques, imaging
is carried out at ambient pressure with little sample preparation
needed at a solid/gas interphase (or in a liquid). However,
deformation or rupture of liposomes might be induced after
deposition onto the AFM sample support due to interaction either
with the carrier material or the cantilever during contact mode
(Laouini et al., 2012; Muraji et al., 2013; Pignataro et al., 2000;
Ruozi et al., 2011). A limitation common for both AFM and Electron
Microscopy is the small sampling area while imaging as a high
number of particles has to be considered to achieve a representa-
tive (i.e. statistically valid) and reliable size characterization.
For size determination and distribution, light scattering
techniques are usually preferred. DLS is nowadays one of the
most common techniques for the determination of liposome and
particle sizes in the nano-range. It gives a fast and reliable reading
with little to no sample preparation (Nickel et al., 2014). DLS is
based on a particle’s light scattering intensity, which gives a
reading of its mean hydrodynamic radius depending on the
particle Brownian motion and is ideal for homogeneous, mono-
disperse samples. However, for more heterogeneous samples,
when small particles are measured in the presence of a few larger
particles, the mean particle diameter will be strongly biased
towards larger constituent sizes (Hupfeld et al., 2006, 2010).
Another limitation seldom taken into account when using DLS is
the PEGylation (steric shield) of stealth liposomes used for drug
delivery. For PEGylated liposomes, the hydrodynamic radii might
give a larger size reading than the actual size of the vesicle.
A strategy to overcome the strong bias of light scattering data to
larger sample components can be found in a preceding size
fractionation technique, such as Field Flow Fractionation (FFF). In
the FFF channel, particles are fractionated based on their size and
then analyzed with light scattering or other detectors(ﬂuorescence, UV–vis, ICP-MS, etc.) (Dubascoux et al., 2010;
Kammer et al., 2005). Although ease of handling for light scattering
as a stand-alone method is lost, its combination with FFF helps to
overcome the problem of small particle masking in the presence of
larger particles (Ranville and Montano, 2015).
Nano electrospray Gas-phase Electrophoretic Mobility Molec-
ular Analysis (nES GEMMA) as an alternative method to analyze
liposomal vesicles separates single charged analytes. These are
obtained from a nES process with subsequent drying of droplets
and charge conditioning in a 210Po induced bipolar atmosphere.
Separation occurs in a high laminar ﬂow of compressed air and an
orthogonal, tunable electric ﬁeld. By variation of the ﬁeld strength
during a voltage scan, only particles of a given size (electrophoretic
mobility, EM, diameter) are able to pass the differential mobility
analyzer (DMA) and are subsequently counted (Bacher et al., 2001;
Kaufman et al., 1996). nES GEMMA allows for single-particle,
number-concentration based detection of analytes and is therefore
in perfect accordance with recommendations of the EU for
nanoparticle characterization (2011/696/EU from October 18th,
2011). In contrast to FFF and DLS, nES GEMMA relates surface-dry
particle diameters. Therefore, the application of volatile electrolyte
solutions for the nES process is a necessary prerequisite for sample
analysis, as else unspeciﬁed analyte/salt aggregates would inter-
fere with vesicle size detection (Weiss et al., 2014).
In a previous study (Weiss et al., 2016), based on work by
Epstein and the group of Biswas (Chadha et al., 2012; Chatto-
padhyay et al., 2010; Epstein et al., 2006) we took nES GEMMA to
the ﬁeld of liposome characterization and analysis of sample
composition to allow for vesicle batch control. The aim of the
present study is to investigate the use of nES GEMMA as a stand-
alone or complementary technique for determining particle size
and size distributions of liposomal drug carriers. This will be done
by comparing nES GEMMA readings to DLS data and SLS coupled to
Asymmetric Flow-FFF (AF4). Additionally, electron microscopy will
be carried out. Correlation of nES GEMMA results to cell viability
experiments demonstrates the importance of liposome character-
ization prior application as drug delivery vesicles.
2. Materials and methods
2.1. Materials
L-a-phosphatidylcholine, hydrogenated (Soy) (HSPC), Choles-
terol (Chol) and 1,2-distearoyl-sn-glycero-3-phosphoethanol-
amine-N-[methoxy(polyethylene glycol)-2000 (DSPE-
mPEG2000) were purchased from Avanti Polar Lipids (Alabaster,
AL, USA). Polystyrene size standard suspensions (20, 60, 100, and
150 nm) from polymer microspheres (Duke Scientiﬁc Corporation,
Palo Alto, CA, USA) used for calibrating the AF4 were prepared in
MilliQ water (18.2 M V cm resistivity at 25 C). All other chemicals
and solutions used were the same as previously described (Weiss
et al., 2016).
2.2. Liposome production
Liposomes of HSPC:Chol:DSPE-mPEG2000 (55:40:5 molar
ratio) were made by the thin lipid ﬁlm hydration technique.
Brieﬂy, phospholipids were dissolved in a round bottomed ﬂask
using a chloroform/methanol (3:1, v/v) mixture. Organic solvents
were evaporated under nitrogen ﬂux until a thin and homogenous
lipid ﬁlm was formed. Traces of organic solvents were removed by
placing the ﬁlms in a desiccator connected to a vacuum pump
(<8 mbar, from Ilmvac, Ilmenau, Germany) for at least one hour at
room temperature. Lipid ﬁlms were hydrated with a 40 mM
ammonium acetate solution, pH 8.4 (NH4OAc), including 10 mM
ATTO633 ﬂuorophore (NH4OAc was ﬁltered through surfactant-
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Sartorius, Göttingen, Germany), by vortex-mixing until lipid ﬁlms
were completely dissolved to achieve a 10 mM lipid concentration
in solution. Multilamellar liposomes were submitted to 5 cycles of
freezing in liquid nitrogen and thawing in a water bath set above
transition temperature of the main lipid (approx. 70 C). Finally,
liposome solutions were serially extruded 21 times each through
400, 200 and 100 nm stacked polycarbonate ﬁlters, respectively, to
yield stock solutions. The liposome preparation process was
repeated for in total n = 5 times to yield nominally identical vesicle
batches.
2.3. nES GEMMA measurements
The TSI Inc (Shoreview, MN, USA) nES GEMMA instrumentation
employed consisted of (i) a nES unit including a 210Po source
(model 3480), (ii) a nano differential mobility analyzer (nDMA,
model 3080) and (iii) an ultraﬁne particle counter (CPC, series
3025A). Compressed, particle-free sheath air for the nES process
(1.0 L/m) was additionally dried (Donaldson Variodry Membrane
Dryer Superplus obtained through R. Ludvik Industriegeräte,
Vienna, Austria). 0.1 Lpm CO2 were likewise included in the nES
sheath ﬂow. Samples were introduced into the nES unit via a cone-
tipped fused silica capillary with 25 mm inner diameter (TSI Inc.)
by application of approx. 28 kPa to the sample vial. The nES was
operated with a positive 2.2 kV voltage resulting in approx.
340 nA current. Scan ranges were set between 4.8–184.3 nm
EM diameter by employment of 2.5 L pm sheath ﬂow in the nDMA.
Scan times were set to 150 s for voltage variation with 30 s retrace
time to allow for a reset of the employed voltage. Between samples,
the capillary was ﬂushed with NH4OAc including 0.0005 [v/v%]
Tween20 followed by blank NH4OAc for capillary equilibration.
Samples were loaded for 5 min before recording of spectra.
Liposomal stock solutions were diluted 1:25 in NH4OAc to obtain
samples (0.4 mM total lipid concentration per sample). Each
sample was measured by four scans. The resulting GEMMA spectra
obtained are medians of these four complete scans, respectively.
Fitting of symmetric, Gauss-shaped peaks to spectra via Origin
software (OriginPro 9.1.0) allowed for EM diameter determination
at the peak apex. If not indicated otherwise, raw count particle
values per detection channel were taken for data analysis. It is of
note that due to analyte heterogeneity resulting in possible
calculation artifacts, we decided to reduce data processing to a
minimum. In a case of raw particle count data evaluation,
additional data correction e.g. for particle charging probabilities
are not considered. However, the correction for size dependent
analyte charging probability would neither inﬂuence the qualita-
tive ﬁndings (detection of smaller sized sample compounds and
determination of dry liposome size values) nor the quantitative
outcome (comparison of liposome encapsulation capacities) of our
study and was therefore omitted.
2.4. Particle size determination by DLS and zeta potential
Mean sizes expressed as Z-averages from cumulant ﬁt analyses
of liposomes were evaluated by dynamic light-scattering using a
Zetasizer (size range: 1 nm–1 mm) (Malvern Instruments, Spring
Lane South, Worcestershire, UK), a photo-correlation spectroscopy
apparatus. The intensity-weighted average hydrodynamic diame-
ter of the suspensions was determined using incident light
(l = 633 nm), detected at a scattering angle of 173.
The material refractive index was set to 1.45, the medium
refractive index was set to 1.33 and the viscosity to 0.887 cP at
20 C. Samples were diluted with NH4OAc. Dilutions at 1:100 and
1:1000 were prepared in a quartz cuvette immediately before
measurement (dilutions had been previously empirically testeduntil attenuator optimal position was achieved). Every sample and
dilution was analyzed three times, each containing 5 sequences
with an integration time of 10 s. All experiments were carried out
at 20 C temperature. Results are given as Z-average. Polydispersity
indices (PDI) were determined with the cumulant analysis method.
2.5. Asymmetric ﬂow-ﬁeld ﬂow fractionation (AF4)
The AF4 equipment used was an Eclipse Dualtech Asymmetric
Field Flow Fractionation system from Wyatt Technology (Dern-
bach, Germany), equipped with a polyether ether ketone spacer of
0.35 mm height and a 10 kDa nominal cutoff regenerated cellulose
membrane (Postnova Analytics, Landsberg, Germany). Liposomal
stock solutions were diluted 1:37 in NH4OAc to obtain samples.
Injection volume was 50 mL for separation runs and 10 mL for
recovery runs. In general, two and three replicates were performed
for separation and recovery runs, respectively. Tip to tip channel
length was 26.5 cm, the detector ﬂow rate was set to 1 mL/min, and
the focus ﬂow rate to 0.8 mL/min with 12 min focusing time. A
shallow cross-ﬂow gradient proﬁle was programmed: the initial
crossﬂow rate was set to 0.8 mL/min and gradually decreased to
0.31 mL/min within 30 min, resulting in a cross-ﬂow reduction rate
of 0.0163 mL/min, which prevents unwanted effects of secondary
relaxation and release of non-fractionated particles from the
membrane due to reduction of the cross-ﬂow to zero during the
analytical run. After 30 min, cross-ﬂow was reduced to 0.15 mL/
min within 5 min, held stable for 5 min at 0.15 mL/min, and ﬁnally
decreased to zero within 3 min. This was done to check if parts of
the sample would elute under very low cross-ﬂow ﬁeld strengths,
although no size information would be obtained from this part of
the analysis. No such parts were observed and fractograms only
originated from the region of the shallow gradient. Due to non-
linearities, questionable applicability of FFF theory and missing
calibration points, no data from the later part of the ﬁeld-program
were used. The carrier solution was 10 mM NaNO3 (Hupfeld et al.,
2006) and was delivered with a 1200 series quaternary pump
(Agilent Technologies, Waldbronn, Germany) equipped with a
micro-vacuum degasser. Detection was achieved by means of a
Dawn EOS multi angle light scattering detector (Wyatt Technology,
Santa Barbara, CA, USA) and a ﬂuorescence detector with excitation
wavelength set to 629 nm, emission wavelength to 657 nm (1200
series FLD, Agilent Technologies, Santa Clara, CA, USA).
Two methods were used to calculate particle size. First, a second
order calibration curve of particle size with retention time was
acquired, using polystyrene standards with 20, 60, 100, and 150 nm
diameter; liposome size was then calculated by converting
retention time to diameter. Second, using the ASTRA software
(Version 5), the spherical model was applied on MALLS data. This
model was used since liposomes were expected to be of spherical
shape.
2.6. Cryogenic transmission electron microscopy (TEM) measurements
Specimens for electron microscopy were prepared in a
controlled environment vitriﬁcation system (CEVS) to ensure
stable temperature and to avoid loss of solution during sample
preparation. The specimens were prepared as thin liquid ﬁlms,
<300 nm thick, on lacey carbon ﬁlmed copper grids and plunged
into liquid ethane at 180 C. This leads to vitriﬁed specimens,
avoiding component segmentation and rearrangement, and water
crystallization, thereby preserving original microstructures. The
vitriﬁed specimens were stored under liquid nitrogen until
measured. An Oxford CT3500 cryoholder and its workstation
were used to transfer the specimen into the electron microscope
(Philips CM120 BioTWIN Cryo) equipped with a post-column
energy ﬁlter (Gatan GIF100). The acceleration voltage was 120 kV.
Fig. 1. nES GEMMA analysis of n = 5 preparations of HSPC:Chol:DSPE-mPEG2000
(55:40:5 molar ratio) liposomes. To demonstrate the repeatability of measurements
four standard spectra of sample 1 are shown (A). (B) Upon mass-concentration
based data analysis, information on smaller-sized sample components is lost. (C)
Calculation of liposome encapsulation capacities based on number-concentration
based nES GEMMA data (percentage of average).
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electron dose conditions.
Analysis of cryo-TEM images was performed using ImageJ 1.50i
software (National Institutes of Health, Bethesda, Maryland). For
each sample, more than 3000 liposomes from over 10 images were
measured and size determined.2.7. Cell culture
The human pancreatic adenocarcinoma cell line BxPc-3 was
purchased from ATCC-LGC Standards (Manassas, VA, USA). The
cells were maintained in RPMI60 (Gibco, Life Technologies, Grand
Island, NY, USA) supplemented with 10% fetal bovine serum and
antibiotics (100 U/ml penicillin and 100 mg/ml streptomycin). The
cells were grown in T-75 culturing ﬂasks (Sarstedt, Nümbrecht,
Germany) and kept in a humidiﬁed 5% CO2 atmosphere at 37 C.
Culturing cell media were changed twice a week and the cells
passaged before reaching conﬂuence. Before experiments, cells
were washed with Dulbecco’s phosphate-buffered saline without
Ca+ or Mg2+ (PBS; Gibco), detached using trypsin-EDTA (Gibco) for
5 min, harvested and pelleted at 1.2  103 rpm for 4 min. After
pellet dissociation by gentle pipetting, cell concentration and
viability were determined using 0.06% trypan blue (Thermo Fisher
Scientiﬁc, Waltham, MA, USA).
2.8. Cell proliferation assays
To assess cellular toxicity, MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) tests were carried out. For the
experiments, cells were seeded (5 103 cells/well) in 96-well
plates in standard culturing medium for 72 h at 37 C, thus allowing
cell adhesion and conﬂuence before changing to serum-free media
(SFM) for 24 h. After 24 h, SFM was removed and replaced with
fresh SFM containing liposomes at different phospholipid con-
centrations. Untreated cells with only SFM at every plate were used
as controls. Following incubation for 24 and 48 h, cell proliferation
was assessed by MTT according to the manufacturer’s instructions
(Roche Life Science, Indianapolis, Indiana, USA). Brieﬂy, 10 mL of
MTT reagent 1 (MTT labeling reagent) was added to each well and
incubated for 4 h at 37 C before adding 100 mL of MTT reagent 2
(solubilization solution, 10% SDS in 0.01 M HCl) and incubating at
37 C before reading plates. The samples were measured on a
Multiskan GO plate reader (test wavelength 595 nm, reference
wavelength 660 nm) using the SkanIt Sotware 3.2 (both Thermo
Fisher Scientiﬁc, Waltham, MA, USA).
2.9. Statistical analysis
Proliferation data are expressed as means  SD of four replicate
wells per plate. Statistical analyses were performed by one-way
ANOVA and Student t-test using GraphPad Prism software
(GraphPad Software Inc., La Jolla, CA, USA). A P-value of <0.05
was considered statistically signiﬁcant.
For statistical analysis and creation of size distribution histo-
grams, size distribution data from cryo-TEM images was exported
from ImageJ software to Graphpad Prism software.
3. Results and discussion
Liposomes were prepared by the thin lipid ﬁlm hydration
technique, followed by repeated freezing and thawing cycles and
serial extrusions through 400, 200 and 100 nm ﬁlters to ensure (i)
an even liposomal size distribution around 100 nm, as well as (ii)
employment of unilamellar vesicles for subsequent analyses.
3.1. nES GEMMA, DLS, AF4 and cryo-TEM measurements
We conducted size and size distribution studies for our
nominally identical liposome batches by means of nES GEMMA,
DLS, AF4 and cryo-TEM measurements.
(i) As already described in the introduction part, nES GEMMA
yields diameters of surface-dry particles. Additionally, data
Fig. 2. DLS data presented for (A) 1–100 dilution and (B) 1–1000 dilution of n = 5
liposome preparations batches in NH4OAc.
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concentrations. For number-based analysis, each nanoparticle
enclosed in a droplet will be counted disregarding their size or
mass. For the latter, information on smaller sized sample
components (present to a varying degree in vesicle prepara-
tions) is lost, as preferentially particles with larger EM
diameter values are displayed. However, as shown in Fig. 1A
applying number-concentration based data analysis on nES
GEMMA derived data, the ﬁve investigated, nominally
identical liposome preparations varied signiﬁcantly in the
amount of low EM diameter sample components (around
20 nm EM diameter). The loss of information on smaller EM
diameter sample compounds becomes evident in Fig. 1B
plotting the same data as Fig. 1A but mass-concentration
based. At the same time (upon mass-concentration based data
evaluation), the EM diameter of the main vesicle peak apex is
shifted to higher EM diameter values as presented in Table 1 as
the mean of at least ﬁve independent readings for each sample
for number- and mass-concentration based data evaluation.
Finally, peak apex values for the main liposome peak of the
ﬁve nominally identical liposome preparations showed a
signiﬁcant variation with EM diameter values between 63.2
and 87.3 nm EM diameter (number-concentration based data).
The measurement method itself exhibited a good repeatability
as demonstrated in Fig. 1A for one representative preparation
batch. (For all batches, intrabatch relative standard deviation
(RStD) values below 1.6%, n  5, were recorded, respectively.)
Hence, the cause of this variation can be traced back to
PEGylated lipid inclusion in liposomes as shown in a previous
study (Weiss et al., 2016). Based on peak apex values as well as
on particle numbers the putative encapsulation capacity of
vesicles can be calculated from obtained particle numbers and
EM diameters, the latter allowing the calculation of vesicle
volumes (Fig. 1C).
(ii) DLS size characterization yields readings of particle hydrody-
namic diameter (Fig. 2). Data in Table 1 is presented as the
mean  standard deviation of three independent analyses at
two different dilutions for the ﬁve nominally identical
liposome preparation batches. DLS readings only showed
one peak for every sample. The mean hydrodynamic diameter
for both dilutions were 132.8  3.5 and 138.5  5.5 nm,
respectively. PDI values (relative PDI for scattering = (peak
width/mean)2) were below 0.1 for all liposome preparations
and no larger species were detectable up to 1 mm particleTable 1
nES GEMMA data showing the EM diameter [nm] for recorded peaks in samples 1–5. Sa
least n = 5 measurements are shown. Number- and mass-based data evaluation is compa
presented as ‘mean diameter  SD’ or ‘mean PDI  SD’ from n = 3 measurements. No sta
sample (calculations not shown here).
Sample nES GEMMA 
Number-based Mass-b
Peak 1 (EM diamter, nm) Peak 2 (EM diameter, nm) EM dia
1 24.0  0.4 69.5  0.6 92.3  0
2 16.8  0.9 85.3  0.4 102.3 
3 21.3  2.8 87.3  0.7 106.6 
4 25.2  0.9 75.7  1.2 95.0  0
5 23.5  0.8 63.2  0.6 84.1  1diameter. Likewise, no smaller sized sample components (as
detected with nES GEMMA upon number-based data evalua-
tion) were detected. This latter ﬁnding was in accordance with
mass-concentration based nES GEMMA data as expected from
a light scattering technique exhibiting a preferential detection
of larger sample compounds.
(iii) We used AF4 for the possibility to separate sample compo-
nents, according to their size, prior to light scattering analysismples were diluted 1:25 in NH4OAc. Average and standard deviation values from at
red. DLS data showing the Z-average in nm for each sample and two dilutions. Data
tistical difference could be found for DLS data between dilutions within the same
DLS
ased Dilution [v/v] Z-average (diameter, nm) Mean PDI
meter (nm)
.5 1–100 133.8  0.9 0.02  0.02
1–1000 147.2  3.5 0.09  0.02
 0.6 1–100 133.8  0.3 0.03  0.01
1–1000 138.9  1.7 0.06  0.02
 0.6 1–100 138.1  1.4 0.01  0.00
1–1000 140.4 + 1.1 0.03  0.01
.7 1–100 129.5  0.9 0.02  0.03
1–1000 131.0  1.4 0.03  0.03
.1 1–100 128.5  1.7 0.02  0.01
1–1000 135.0  3.4 0.03  0.02
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that even though particle separation occurs, which in
principle simpliﬁes the detection of multimodal size distri-
butions in static light scattering as a series of measurements is
performed on nearly monodisperse sample fractions, the
sensitivity of the system decreases with decreasing particle
size, as demonstrated in Fig. 3A for polystyrene size standards
of comparable concentrations (5–10 ppm). Overall, for the
setup used in this study, particles smaller than approximately
50 nm would pre-elute and may be inﬂuenced by the void
peak (Kammer et al., 2005).
Nominally identical liposome preparation batches demonstrat-
ed similar fractograms (Fig. 3B–F). Hydrodynamic diameters were
obtained by means of a calibration curve with polystyrene
standards; in addition, geometric diameter was obtained by
means of the multi-angle laser light scattering (MALLS). Overall,
there was good agreement between the hydrodynamic diameter
and the geometric diameter, which veriﬁes that the liposomes are
of spherical shape and fractionation occurs according to FFF theory
in normal mode. Only for samples 1 and 5 and to a lesser extent
sample 2, could small differences be seen between the geometric
and hydrodynamic radius, indicating a possible deviation from the
spherical shape, interactions of the particles with the membrane or
multimodal particle size distributions.
Concerning the size differences for vesicles detected with AF4
when compared to nES GEMMA, it should be noted that very small
particles (in the order of 20 nm) may not have been in large enough
numbers to produce a readable intensity of scattered light in the
MALLS detector of the AF4 system. An incontrovertible evidence
for smaller-sized particle components on AF4 measurements alone
is therefore not possible. However, smaller sized sample compo-
nents in the order of 20 nm were indeed detected via nES GEMMA
upon number-based data evaluation. Furthermore, samples 1 andFig. 3. MALLS signal (detector at 90) over retention time for AF4 fractograms (solid blac
standard mix of 20, 60, 100, and 150 nm diameter (shown as solid squares). The detecta
samples 1, 2, 3, 4, and 5, respectively. Also shown are geometric diameters calculated from
calibration curve calculated from the elution time of the PS standards (dashed black li5 exhibited peak shapes that are not completely Gaussian, showing
a shoulder towards the smaller size range (compare Fig. 3B and F).
The same tendency can be seen for sample 1 and 5 in the DLS
readings where they have the highest difference between dilutions
of all samples as well as the highest standard deviation. This is
evidence that these two samples contained a larger number of
particles below the mean as compared to samples 2, 3, and 4 and
explains differences in geometric and hydrodynamic radii for these
samples.
(iv) Representative cryo-TEM images for liposome preparation
batches 1 and 3 are shown in Fig. 4 as well as their respective
size distribution histograms. Sample 1 and 3 were selected for
imaging as they show again the most and least pronounced,
respectively, peaks for low diameter populations in nES
GEMMA analysis. Sample 1 clearly shows the presence of
many small diameter liposomes. In contrast, sample 3,
although still showing the presence of small diameter
populations, the frequency at which these small-diameter
liposomes were observed was clearly less than for sample 1.
These observations were corroborated by creating size
distribution histograms by measuring more than 3000
particles from over 10 images for each sample. For sample
1, the smallest recorded liposome was at 16 nm in diameter
and 20.42% of the total observed liposome population below
60 nm in diameter. For sample 3 on the other hand, the
smallest recorded liposome was at 22 nm diameter and 10.22%
of the total observed liposome population below 60 nm in
diameter conﬁrming that there indeed was a larger presence
of low diameter liposomes in sample 1. Finally, the size
distribution histograms clearly show a bimodal size distribu-
tion for sample 1 and a unimodal size distribution for sample
3, hence, corroborating nES GEMMA number-concentration
based data.k lines) of PS standards and ﬁve liposome preparation batches. (A) Fractogram of PS
bility of PS particles decreases with their size. (B), (C), (D), (E), (F): Fractograms of
 MALLS data using the spherical model (grey dots) and the hydrodynamic diameter
ne).
Fig. 4. Cryo-Transmission Electron Microscopy (cryo-TEM) images of liposomal samples (A) 1 and (B) 3 and their respective size distribution histograms in (C) and (D). In
sample 1 there is a larger presence of small diameter liposomal populations compared to sample 3 (in accordance with number-based nES GEMMA data). Dark spots pointed
out by an arrow in (A) are due to frost artifacts. Size distribution histograms of samples 1 (C) and 3 (D) conﬁrmed the same size distributions as seen in nES GEMMA data. For
the histograms, more than 3000 particles from several TEM images were counted and measured.
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preparation batches
Analyte characterization via nES GEMMA yields surface-dry
particle diameters and enables the calculation of particle volumes
and thereof encapsulation capacities. DLS and AF4-MALLS in
contrast yield hydrodynamic and geometric diameter values,
which differ signiﬁcantly from dry particle diameters; not only but
also due to PEG-chains on the surface of vesicles being solvated and
moving freely when in contact with a liquid but collapsing on a dry
particle. Nevertheless, hydrodynamic values are necessary to
estimate the behavior of vesicles in suspension, which is especially
of importance when vesicles are administered in that form.
Furthermore, AF4 with SLS and standalone DLS enables the
detection of analytes and vesicle aggregates, whose size exceeds by
far the detectable EM diameter range of the current nES GEMMA
setup (mind that other GEMMA setups allow detection of particles
up to 1 mm EM diameter and above). However, DLS detection alone
is not capable to characterize bi- or multimodal analyte size
distributions, even though various methods exist to transform the
correlation curve to a size distribution, due to the limited size-
resolution offered by the technique and the preferential detectionof larger components. This effect can likewise be demonstrated by
number- and mass-based evaluation of the same set of data
obtained from nES GEMMA measurements. Upon mass-based data
evaluation, information on smaller sized sample components is
lost. These ﬁndings are supportive of the EU recommendations
concerning nanoparticle characterization based on number con-
centrations (2011/696/EU from October 18th, 2011).
Occurrence of low EM diameter material inﬂuences (i) the
overall size distribution in preparations as well as (ii) the number
of larger liposomes due to inclusion of lipids in low EM diameter
material instead of larger vesicles. Hence, the detection of low EM
diameter material is of importance. The problem of bias in the
intensity-based analyte detection via DLS is partially circumvented
upon application of AF4 in combination with MALLS, a SLS
detection system. Particle size separation prior to detection allows
for separation of particles in a multimodal distribution and
improves the detectors capabilities. However, the dependence of
signal intensities on particle size in MALLS reduces the sensitivity
for small particles with diameters <50 nm. In principle, the
intensity signal from any of the MALLS angles reﬂects a similar
intensity-weighted characteristic as DLS shows. On top of the
intensity-weighted signals from MALLS the detection principle
relies on the mass of the particles in the detector. If the number-
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based distribution, there are clear similarities between both
techniques. However, AF4/MALLS results alone are not sufﬁcient to
demonstrate unambiguously the occurrence of a multimodal
particle-number size distribution when such particles are present
and information from additional methods is necessary.
Cryo-TEM reﬂects the multimodal size distribution of analytes
besides giving a notion on overall vesicle shape and lamellarity.
However, the large number of vesicle images necessary to obtain
statistically valid information on liposomes renders this technique
time- and cost-consuming. Nevertheless, cryo-TEM data supports
our nES GEMMA ﬁndings, whereas AF4/MALLS and DLS failed to
detect the presence of smaller-sized sample components. To
conclude, besides differences in the determined liposome size
(surface-dry particle diameters vs. hydrodynamic diameter values)
employed analytical methods for vesicle characterization show
differences especially in the detection of lower sized sample
material. If this material indeed has an inﬂuence on the
toxicological behavior of liposomes upon application as carrier
vesicles will be targeted in the following section.
3.3. Does smaller-sized material inﬂuence cytotoxicity of liposome
carriers?
To assess whether the low diameter populations detected,
especially in samples 1 and 5, during nES GEMMA measurementsFig. 5. In-vitro dose- and time-dependent cytotoxic effect induced by liposomal samples
as percent of control (untreated cells). Results are means  standard deviation, n = 4 frohad a cytotoxic effect for bare vesicles, the cytotoxic proﬁles of the
liposomal samples were acquired on BxPC-3 Pancreatic Cancer
cells using the MTT assay (Fig. 5). Liposomes were diluted to match
lipid concentrations similar to the ones used in studies where
liposomal drug delivery was tested (Papa et al., 2012). For each
sample and concentration, four replicates were made. Results in
Fig. 5 are presented as “% of control” where control cells were left
untreated, adding only SFM during incubation periods.
The assays showed a clear correlation between increased
cytotoxic effect and the presence of low diameter material.
Samples 1 and 5 which showed the largest presence of small
diameter particles in nES GEMMA measurements, induced a
signiﬁcantly higher cytotoxic effect compared to samples 4 and
especially, 2 and 3 which showed the lowest presence of small
diameter particles. Liposomal sample 2 showed the least cytotoxic
effect and a signiﬁcant difference compared to samples 1 and 5
could be seen for both 24 and 48 h. However, compared to samples
3 and 4, a signiﬁcant difference in cytotoxic effect could only be
seen at 24 h. Blank cells were treated with SFM and liposomal
suspension medium at same dilution as liposomal samples. No
signiﬁcant cytotoxic effect could be seen from suspension medium
compared to control cells. This indicates that even a small presence
of low diameter material might have an undesired cytotoxic effect
on cells. A summary of comparison between liposomal samples
can be found in Table 2 underscoring the above mentioned
differences between liposome preparations. on BxPC-3 cells. Analysis was performed by a standard MTT assay. Data are reported
m two different experiments.
Table 2
P-value and statistical signiﬁcance of sample 2 and 3 in comparison to each other
and liposomal samples 1, 4 and 5.
(a) 24 h
Concentration Sample 1 2 3 4 5
62,5 2 0.0002 – 0.007 0.0011 0.0002
*** – ** ** ***
3 0.003 0.007 – 0.7768 0.0002
*** ** – n.s. ***
125 2 0.002 – 0.0148 0.0648 0.0002
*** – * n.s. ***
3 0.0002 0.0148 – 0.854 0.0002
*** * – n.s. ***
250 2 0.0002 – 0.006 0.0002 0.0002
*** – *** *** ***
3 0.0002 0.006 – 0.7768 0.0003
*** *** – n.s. ***
(b) 48 h
Concentration Sample 1 2 3 4 5
62,5 2 0.0002 – >0.99 >0.99 0.003
*** – – n.s. **
3 0.0002 >0.99 – 0.3754 0.0002
*** – – n.s. ***
125 2 0.0011 – 0.7768 0.7768 0.0006
** – – n.s. ***
3 0.0002 0.7768 – 0.4331 0.0002
*** n.s. – n.s. ***
250 2 0.0002 – 0.1296 0.2317 0.0002
*** – n.s. n.s. ***
3 0.0002 0.1296 – 0.7768 0.0002
*** n.s. – n.s. ***
n.s. stands for p > 0.05.
* p  0.05.
** p  0.01.
*** p  0.001.
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The aim of our current work was to compare several
independent, i.e. based on different physical principles, analysis
methods in the characterization of liposomal vesicles applicable
for drug delivery. In doing so we were able to highlight the ability of
nES GEMMA to target surface-dry nanoparticles with number-
concentration based analyte detection. Hence, differences between
nominally identical liposome preparations concerning the size of
liposomes and the presence of lower-sized sample material were
demonstrated. These differences cannot be detected by DLS alone
as the measurement is biased by the presence of preferentially
detected larger particles. Additionally, it has to be considered that
DLS yields overall higher diameter values (hydrodynamic radii vs.
dry particles). Coupling of SLS detection with a preceding
separation step (AF4) leading to separation of smaller and larger
sample components did not allow detection of the multimodal size
distribution, likely due to decreased detection sensitivity in the
lower particle size range. In contrast, this multimodal particle size
distribution of vesicles is demonstrated by cryo-TEM, a method
that additionally allows the assessment of liposome lamellarity.
Overall, it has to be stressed that especially the combination of
independent analysis techniques allows an as complete as possible
characterization of carrier vesicle preparations concerning (i)
analyte size, (ii) lamellarity and (iii) the occurrence of lower-sized
sample components. The latter information can be deduced from
number-concentration based nES GEMMA data. From our data, it
appears that lower-sized sample components play a major role in
in vitro cytotoxicity as preparation batches with larger amounts oflower-sized particles exhibited a larger cytotoxic effect in cell
culture. However, more experiments in the in vitro ﬁeld are
necessary in order to further strengthen our ﬁndings.
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